A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency - Yeung, T W; Li, R H; Lee, V C; Ho, P C; Ng, E H (J Clin Endocrinol Metab, 2013)